Mechanistically, researchers have demonstrated that TAMs activate the AKT signaling pathway in tumor cells by secreting chemokine ligand 2 (CCL2), which promotes the expression and nuclear localization of β-catenin and thus promotes EMT and CSC properties of TNBC tumor cells. This evidence concerns the gene CCL2 and neoplasm.